Horizon Therapeutics plc announced in January that it signed a long-term, full-building lease with Alexandria Real Estate Equities, Inc. to be the first tenant at the Alexandria Center® at Traville Gateway campus in Rockville, Maryland. The 192,000-square foot building with a five-level parking garage containing up to 562 spaces is currently being constructed for Research and Development use at 9810 Darnestown Rd next to the Travilah Square shopping center.
When completed, the state-of-the-art facility will serve as the company’s primary East Coast research and development and technical operations hub. Construction at the nearly 200,000-square-foot site is underway and Horizon expects to start work on interior improvements in 2023. Additional terms of the agreement were not disclosed.
“Maryland has one of the fastest growing biotechnology communities in the country with a world-class talent pool of scientists and researchers,” said Tim Walbert, chairman, president and chief executive officer, Horizon. “With this new facility we are more than quadrupling our current Marylandfootprint and creating a hub that will support job growth, drive our company’s continued efforts to develop new medicines for patients with rare, autoimmune and severe inflammatory diseases and meet the needs of our expanding pipeline. We look forward to expanding our presence in Maryland and appreciate the support from local, state and federal officials who recognize the economic and community value of the life science industry.”
“It is exciting news that Horizon Therapeutics has chosen Maryland for a significant expansion, which will enable the company to continue its important work in treating people impacted by rare, autoimmune and severe inflammatory diseases,” said Governor Larry Hogan. “It is a testament to our outstanding business climate and wealth of resources that we have seen so many life sciences companies expand and add thousands of new jobs in our state in recent years.”